Recombinant Rat FADS2 is produced by inserting the rat Fads2 gene into bacterial expression systems (e.g., E. coli), enabling large-scale purification for experimental use . Key functions include:
Δ6-Desaturase Activity: Introduces a double bond at the Δ6 position of fatty acid substrates, initiating PUFA synthesis .
Membrane Integration: Operates as a multi-pass endoplasmic reticulum membrane protein, requiring cytochrome b5 domains for electron transfer during catalysis .
Physiological Impact: PUFA products like arachidonic acid (AA) and eicosapentaenoic acid (EPA) influence inflammation, fertility, and cancer progression .
Recombinant Rat FADS2 is typically expressed in E. coli with affinity tags (e.g., His-tag) for purification . Key parameters include:
Recombinant Rat FADS2 is widely used to investigate:
Lipid Metabolism: Elucidates PUFA biosynthesis pathways and their regulation in rodents .
Disease Models: Studies link FADS2 dysregulation to cancer, infertility, and inflammatory disorders .
Drug Development: Screens for inhibitors targeting PUFA-driven tumor progression .
Recent studies highlight its functional versatility:
Knockout Effects: Fads2−/− mice exhibit infertility due to disrupted blood-testis barrier integrity and impaired spermatogenesis .
Substrate Flexibility: Rat FADS2 demonstrates activity toward multiple substrates, including 18:2n-6, 18:3n-3, and 16:0 .
Thermostability: Retains activity at 4°C for one week post-reconstitution, making it suitable for extended assays .
Rat FADS2 shares 85% sequence homology with human FADS2 but lacks Δ5-desaturase activity present in human isoforms . Unlike marine fish FADS2, it does not exhibit Δ4-desaturase activity, limiting its role in docosahexaenoic acid (DHA) synthesis .